{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:38:06Z","timestamp":1789558686320,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0466-x","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T04:08:43Z","timestamp":1491970123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent\u2014Meclizine HCl"],"prefix":"10.1186","volume":"16","author":[{"given":"Faaiza","family":"Qazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia Ismail","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Iqbal","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"466_CR1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0091270011414575","volume":"52","author":"Z Wang","year":"2012","unstructured":"Wang Z, Lee B, Pearce D, Qian S, Wang Y, Zhang Q, Chow MS. Meclizine metabolism and pharmacokinetics: formulation on its absorption. J Clin Pharmacol. 2012;52:1343\u20139.","journal-title":"J Clin Pharmacol"},{"key":"466_CR2","first-page":"141","volume":"34","author":"GM Mahrous","year":"2011","unstructured":"Mahrous GM, Shazly GA, Ibrahim MA. Formulation and evaluation of meclizine HCl orally disintegrating tablets. Bull Pharm Sci. 2011;34:141\u20138.","journal-title":"Bull Pharm Sci"},{"key":"466_CR3","unstructured":"Symphonyhealth: \nhttp:\/\/symphonyhealth.com\/wp-content\/uploads\/2015\/05\/Top-200-Drugs-of-2014.pdf\n\n (accessed: 25.03.17)2017."},{"key":"466_CR4","unstructured":"PfizerProductsAntivert: \nhttps:\/\/www.pfizerpro.com\/pfizer-products\n\n. (accessed: 25.03.17) 2017."},{"key":"466_CR5","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1208\/pt0803074","volume":"8","author":"R Singh","year":"2007","unstructured":"Singh R, Poddar S, Chivate A. Sintering of wax for controlling release from pellets. AAPS PharmSciTech. 2007;8:E175\u201383.","journal-title":"AAPS PharmSciTech"},{"key":"466_CR6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejpb.2009.05.007","volume":"73","author":"H Kranz","year":"2009","unstructured":"Kranz H, J\u00fcrgens K, Pinier M, Siepmann J. Drug release from MCC-and carrageenan-based pellets: experiment and theory. Eur J Pharm Biopharm. 2009;73:302\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"466_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2003.10.017","volume":"271","author":"T Pongjanyakul","year":"2004","unstructured":"Pongjanyakul T, Medlicott NJ, Tucker IG. Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int J Pharm. 2004;271:53\u201362.","journal-title":"Int J Pharm"},{"key":"466_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(03)00229-1","volume":"260","author":"J Hamdani","year":"2003","unstructured":"Hamdani J, Mo\u00ebs AJ, Amighi K. Physical and thermal characterisation of Precirol\u00ae and Compritol\u00ae as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm. 2003;260:47\u201357.","journal-title":"Int J Pharm"},{"key":"466_CR9","first-page":"98","volume":"28","author":"S Cheboyina","year":"2004","unstructured":"Cheboyina S, Chambliss WG, Wyandt CM. A novel freeze Pelletization technique for preparing Matix pellets. Pharm Technol. 2004;28:98\u2013111.","journal-title":"Pharm Technol"},{"key":"466_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2008.04.001","volume":"359","author":"S Cheboyina","year":"2008","unstructured":"Cheboyina S, Wyandt CM. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique: II. In vitro drug release studies and release mechanisms. Int J Pharm. 2008;359:167\u201373.","journal-title":"Int J Pharm"},{"key":"466_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejpb.2011.07.004","volume":"79","author":"E Roblegg","year":"2011","unstructured":"Roblegg E, J\u00e4ger E, Hodzic A, Koscher G, Mohr S, Zimmer A, Khinast J. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur J Pharm Biopharm. 2011;79:635\u201345.","journal-title":"Eur J Pharm Biopharm"},{"key":"466_CR12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/156720109787048339","volume":"6","author":"MA Rahman","year":"2009","unstructured":"Rahman MA, Ahuja A, Baboota S, Bali V, Saigal N, Ali J. Recent advances in pelletization technique for oral drug delivery: a review. Current drug delivery. 2009;6:122\u20139.","journal-title":"Current drug delivery"},{"key":"466_CR13","doi-asserted-by":"crossref","unstructured":"Nasiri MI, Yousuf RI, Shoaib MH, Fayyaz M, Qazi F, Ahmed K. Investigation on release of highly water soluble drug from matrix-coated pellets prepared by extrusion\u2013spheronization technique. J Coat Technol Res. 2016:1\u201312.","DOI":"10.1007\/s11998-015-9749-1"},{"key":"466_CR14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s11095-015-1661-y","volume":"32","author":"K Becker","year":"2015","unstructured":"Becker K, Salar-Behzadi S, Zimmer A. Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm Res. 2015;32:1519\u201345.","journal-title":"Pharm Res"},{"key":"466_CR15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1208\/s12249-015-0297-x","volume":"16","author":"Z Gao","year":"2015","unstructured":"Gao Z, Yu L, Clark S, Trehy M, Moore T, Westenberger B, Buhse L, Kauffman J, Bishop B, Velazquez L. Dissolution Testing for bioavailability of over-the-counter (OTC) drugs\u2014a technical note. AAPS PharmSciTech. 2015;16:1227.","journal-title":"AAPS PharmSciTech"},{"key":"466_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/17425247.2011.547469","volume":"8","author":"D Shukla","year":"2011","unstructured":"Shukla D, Chakraborty S, Singh S, Mishra B. Lipid-based oral multiparticulate formulations\u2013advantages, technological advances and industrial applications. Expert opinion on drug delivery. 2011;8:207\u201324.","journal-title":"Expert opinion on drug delivery"},{"key":"466_CR17","unstructured":"GattefosseProducts: \nhttp:\/\/www.gattefosse.com\/en\/applications\/?administration-route,oral,substained-release\n\n. (accessed:25.03.17) 2017."},{"key":"466_CR18","first-page":"1058","volume":"8","author":"BR Pezzini","year":"2014","unstructured":"Pezzini BR, Grossl AD, Muraro A, Bazzo GC, Soares L. Formulation and in vitro assessment of sustained release matrix tablets of atenolol containing Kollidon SR and carnauba wax. Afr J Pharm Pharmacol. 2014;8:1058\u201365.","journal-title":"Afr J Pharm Pharmacol"},{"key":"466_CR19","first-page":"282","volume":"6","author":"MS Reza","year":"2003","unstructured":"Reza MS, Quadir MA, Haider SS. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharm Sci. 2003;6:282\u201391.","journal-title":"J Pharm Pharm Sci"},{"key":"466_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpb.2006.02.005","volume":"63","author":"M \u00d6zyaz\u0131c\u0131","year":"2006","unstructured":"\u00d6zyaz\u0131c\u0131 M, G\u00f6k\u00e7e EH, Ertan G. Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm. 2006;63:331\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"466_CR21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1208\/pt040461","volume":"4","author":"KR Reddy","year":"2003","unstructured":"Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech. 2003;4:480\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"466_CR22","first-page":"17","volume":"16","author":"MA Quadir","year":"2003","unstructured":"Quadir MA, Rahman MS, Karim MZ, Akter S, Awkat M, Reza M. Evaluation of hydrophobic materials as matrices for controlled-release drug delivery. Pak J Pharm Sci. 2003;16:17\u201328.","journal-title":"Pak J Pharm Sci"},{"key":"466_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2478\/acph-2013-0002","volume":"63","author":"B Wilson","year":"2013","unstructured":"Wilson B, Babubhai PP, Sajeev MS, Jenita JL, Priyadarshini BSR. Sustained release enteric coated tablets of pentaprazole: formulation, in vitro and in vivo evaluation. Acta Pharma. 2013;63:131\u201340.","journal-title":"Acta Pharma"},{"key":"466_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40005-013-0112-1","volume":"44","author":"PB Parejiya","year":"2014","unstructured":"Parejiya PB, Barot BS, Patel HK, Mehta DM, Shelat PK, Shukla A. Release modulation of highly water soluble drug using solid dispersion: impact of dispersion and its compressed unit. Journal of Pharmaceutical Investigation. 2014;44:163\u201375.","journal-title":"Journal of Pharmaceutical Investigation"},{"key":"466_CR25","unstructured":"USP 38 NF 33: U.S. Pharmacopeia National Formulary. Rockville: The United States Pharmacopeial Convention; 2015."},{"key":"466_CR26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.powtec.2012.08.019","volume":"233","author":"B Chamsai","year":"2013","unstructured":"Chamsai B, Sriamornsak P. Novel disintegrating microcrystalline cellulose pellets with improved drug dissolution performance. Powder Technol. 2013;233:278\u201385.","journal-title":"Powder Technol"},{"key":"466_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(99)00302-6","volume":"192","author":"F Podczeck","year":"1999","unstructured":"Podczeck F, Rahman S, Newton J. Evaluation of a standardised procedure to assess the shape of pellets using image analysis. Int J Pharm. 1999;192:123\u201338.","journal-title":"Int J Pharm"},{"key":"466_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ces.2012.04.037","volume":"86","author":"T Kitak","year":"2013","unstructured":"Kitak T, Govedarica B, Sr\u010di\u010d S. Physical properties of pharmaceutical pellets. Chem Eng Sci. 2013;86:50\u201360.","journal-title":"Chem Eng Sci"},{"key":"466_CR29","unstructured":"FDADissolution: \nhttp:\/\/www.accessdata.fda.gov\/scripts\/cder\/dissolution\/index.cfm\n\n (accessed 11.03.16). 2016."},{"key":"466_CR30","first-page":"653","volume":"26","author":"F Qazi","year":"2013","unstructured":"Qazi F, Shoaib MH, Yousuf RI, Qazi TM, Mehmood ZA, Hasan SMF. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M. Pak J Pharm Sci. 2013;26:653\u201363.","journal-title":"Pak J Pharm Sci"},{"key":"466_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123\u201333.","journal-title":"Eur J Pharm Sci"},{"key":"466_CR32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1208\/s12249-013-9951-3","volume":"14","author":"A Abd-Elbary","year":"2013","unstructured":"Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Sucrose stearate-enriched lipid matrix tablets of etodolac: modulation of drug release, diffusional modeling and structure elucidation studies. AAPS PharmSciTech. 2013;14:656\u201368.","journal-title":"AAPS PharmSciTech"},{"key":"466_CR33","first-page":"555","volume":"4","author":"KJ Wadher","year":"2010","unstructured":"Wadher KJ, Kakde RB, Umekar MJ. Formulations of sustained release metformin hydrochloride tablet using combination of lipophilic waxes by melt granulation technique. Afr J Pharm Pharmacol. 2010;4:555\u201361.","journal-title":"Afr J Pharm Pharmacol"},{"key":"466_CR34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1081\/DDC-200040237","volume":"30","author":"X Gu","year":"2004","unstructured":"Gu X, Fediuk DJ, Simons FER, Simons KJ. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. Drug Dev Ind Pharm. 2004;30:1009\u201317.","journal-title":"Drug Dev Ind Pharm"},{"key":"466_CR35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejpb.2009.05.007","volume":"73","author":"H Kranz","year":"2009","unstructured":"Kranz H, Jurgens K, Pinier M, Siepmann J. Drug release from MCC- and carrageenan-based pellets: experiment and theory. Eur J Pharm Biopharm. 2009;73:302\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"466_CR36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0975-1483.83758","volume":"3","author":"S Jagdale","year":"2011","unstructured":"Jagdale S, Patil S, Kuchekar B, Chabukswar A. Preparation and characterization of Metformin hydrochloride\u2212 Compritol 888 ATO solid dispersion. J Young Pharm. 2011;3:197\u2013204.","journal-title":"J Young Pharm"},{"key":"466_CR37","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3109\/03639045.2011.645829","volume":"38","author":"X Yan","year":"2012","unstructured":"Yan X, He H, Meng J, Zhang C, Hong M, Tang X. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion\/spheronization and an investigation of their stability. Drug Dev Ind Pharm. 2012;38:1221\u20139.","journal-title":"Drug Dev Ind Pharm"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0466-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T14:21:07Z","timestamp":1496672467000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0466-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0466-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]},"article-number":"75"}}